Hong Kong vs Singapore IVF Success Rate: An Objective Analysis Based on Real Data
IVF success rates in Hong Kong and Singapore are influenced by multiple factors, including patient age, ovarian reserve, reproductive center statistical methods, and technical standards. This article provides an objective comparison from dimensions such as clinical indicators, regulatory policies, and embryo culture differences, helping to rationally evaluate the characteristics and selection criteria of assisted reproduction in the two regions.
Opening: Real Consultation Scenario
Last month, a 42-year-old patient with an AMH of 0.8 ng/mL asked me during a remote consultation: "Which has a higher IVF success rate, Singapore or Hong Kong? Where should I go?" She had two reports in hand—one from a reproductive center in Hong Kong and one from a hospital in Singapore. Both stated a "success rate of about 40%," but she didn't know how to decide.
I have encountered this scenario many times over the past year. The success rate is the most concerning indicator for patients when choosing a treatment location, but it is also the most easily misinterpreted number. Below, I analyze the real differences in IVF success rates between Hong Kong and Singapore from several key dimensions, and how to judge based on your own situation.
Structural Differences Behind the Success Rate Numbers
Direct answer: The IVF success rates in Hong Kong and Singapore are both in the top tier in Asia, but the statistics cannot be directly compared. The live birth rate for people under 35 reported by some reproductive centers in Hong Kong is about 45%–50%, while the comparable data in Singapore is about 40%–45%. The differences mainly come from three structural factors: patient selection criteria, statistical methods (whether cumulative success rates including frozen embryo transfers are included), and embryo culture and genetic testing strategies.
Doctor's perspective: When interpreting success rates, reproductive doctors do not look at just one number. What we care more about is—"What is the expected live birth rate for you, given your age and ovarian reserve?" Doctors in both regions will make individualized assessments based on AMH, FSH, antral follicle count (AFC), and past reproductive history. For a 42-year-old patient with an AMH of 0.8, the expected live birth rate at top centers in either region would not exceed 15%. At this point, it is not very meaningful to dwell on "which place has a higher average success rate." What is more important is: Which ovulation induction protocol is better suited to your ovarian response type? What is the embryo lab's experience with blastocyst culture?
Why are there these differences? The regulatory frameworks for assisted reproduction differ between Hong Kong and Singapore. Hong Kong follows the HFEA (Human Fertilisation and Embryology Authority) system, with strict indications for embryo genetic testing (PGT), and tends towards fewer transfers and single embryo transfer. Singapore is regulated by the MOH (Ministry of Health), with slightly different policies regarding embryo culture duration and genetic screening. These regulatory differences directly affect the statistical values of "live birth rate per transfer cycle" and "cumulative live birth rate."
How Regulatory Framework and Policy Differences Affect Treatment Choices
There are several key legal differences in assisted reproduction between Hong Kong and Singapore that directly determine what treatment options are available to you:
| Comparison Dimension | Hong Kong | Singapore |
|---|---|---|
| PGT (Preimplantation Genetic Testing) | Limited to specific genetic disease indications; not allowed for sex selection or non-medical trait screening. The regulatory approval process is longer. | Allowed for specific genetic risks, with clearer guidelines. Some centers are open to preimplantation genetic testing for aneuploidy (PGT-A), depending on age and embryo condition. |
| Egg/Sperm Donation | Anonymous donation; donor information is strictly confidential. Sources of donated eggs are limited, with longer waiting times. | Allows both anonymous and known donation, with a national-level coordination mechanism for donations. The egg bank resource is relatively transparent. |
| Embryo Freezing and Storage | Frozen embryo storage is generally limited to 10 years, requiring periodic renewal of informed consent. | Storage period is flexible; some centers can extend it up to the patient's maximum age limit. Annual fees vary significantly. |
| Single Embryo Transfer Policy | Strongly recommends single embryo transfer, especially for patients under 35. Double embryo transfer requires a medical reason. | Also advocates for single embryo transfer, but with more detailed guidelines based on patient age and embryo quality. |
The above policies are based on public information compiled in 2024. Please refer to the latest regulations of each reproductive center for specific implementation details.
Impact on success rate: Singapore is relatively more flexible in the application of PGT-A, potentially offering more embryo selection options for older patients or those with repeated implantation failure. Hong Kong is stricter in implementing single embryo transfer, which may lower the "live birth rate per single transfer cycle" but significantly reduces the risk of multiple pregnancies, which is an advantage from the perspective of maternal and infant safety.
Easily Overlooked Statistical Method Issues
This is the most easily overlooked detail when comparing success rates between the two regions, and it is also the main reason patients are misled.
- Different denominators: Some institutions report the "live birth rate per transfer cycle" (only counting cycles where an embryo transfer was performed). The denominator is smaller, so the number is naturally higher. Others report the "live birth rate per initiated cycle" (including cycles cancelled due to poor ovarian response, no eggs retrieved, or no embryos formed). The denominator is larger, making the number lower but more realistic.
- Whether frozen embryo transfers are included: Reporting only the success rate of fresh embryo transfers underestimates the ultimate live birth chance from the entire egg retrieval cycle. The cumulative live birth rate (the probability of live birth from all fresh + frozen embryo transfers within one egg retrieval cycle) is a more comprehensive indicator.
- Whether age stratification is clear: Some centers publish an overall success rate as the "average for all patients." If the center has a high proportion of young patients, the average number will be inflated, offering limited reference value for older patients.
Real case: A 38-year-old patient started a cycle at a center in Hong Kong. 10 eggs were retrieved, 5 blastocysts were formed, and 2 were transferable after PGT screening. The first fresh transfer did not result in pregnancy, but the second frozen embryo transfer led to a successful live birth. If you only look at the "fresh transfer live birth rate," this cycle at the center was a "failure." However, the cumulative live birth rate was 50%. Another institution might report a "live birth rate per transfer cycle" of 50%, which looks the same, but the denominator and numerator are completely different.
Common Pitfalls When Choosing a Treatment Location
Based on my ten years of professional observation, patients are most prone to the following judgment errors when comparing success rates between the two regions:
- Being fixated on "success rate rankings": Ignoring one's own age and ovarian reserve. It is meaningless for a 42-year-old patient to refer to the "average success rate for people under 35."
- Overlooking differences in lab quality: Embryo culture is the core of IVF, but the success rate number reflects the combined result of "doctor + lab + nursing care." Some centers have experienced doctors but average lab conditions, while others are the opposite.
- Underestimating travel and time costs: Although Singapore and Hong Kong are geographically close, a treatment cycle typically requires 2–3 weeks per visit. The costs of accommodation, transportation, and time off work for multiple trips need to be factored into the decision.
- Not being aware of genetic testing policy restrictions: If a patient has a clear genetic disorder or is at high risk for chromosomal abnormalities due to advanced age, they need to confirm in advance whether the destination allows PGT and what the approval process is.
Risk reminder: Do not make a decision immediately just because an institution reports a "60% success rate." First, ask clearly: What age group does this success rate apply to? What is the statistical method? Does it include frozen embryo transfers? Is the data from the past year or accumulated over many years? If the institution cannot clearly answer these questions, the reference value of this number should be discounted.
Evaluation Standards for Key Fertility Indicators in Both Regions
Reproductive centers in Hong Kong and Singapore are largely consistent in basic examination items, but there are subtle differences in specific reference ranges and interpretation habits:
| Indicator | Common Reference Range in Hong Kong | Common Reference Range in Singapore | Explanation of Interpretation Differences |
|---|---|---|---|
| AMH (Anti-Müllerian Hormone) | 1.0–4.0 ng/mL (normal) 0.5–1.0 (low) <0.5 (significantly decreased) |
0.8–3.5 ng/mL (normal) 0.4–0.8 (low) <0.4 (significantly decreased) |
Some laboratories in Singapore use different testing platforms, with a slightly lower reference limit, but clinical decision thresholds are similar. |
| FSH (Follicle-Stimulating Hormone) | <10 IU/L (normal) 10–15 (borderline) >15 (indicates diminished ovarian reserve) |
<9 IU/L (normal) 9–13 (borderline) >13 (diminished reserve) |
Hong Kong more commonly uses 10 as the cutoff; some centers in Singapore use 9. The difference is minimal. |
| Antral Follicle Count (AFC) | Total for both ovaries: 8–15 (normal) 5–7 (low) <5 (significantly decreased) |
Total for both ovaries: 7–14 (normal) 4–6 (low) <4 (significantly decreased) |
Differences in the counter's experience may cause a fluctuation of 1–2, which does not affect clinical stratification. |
Overall, the evaluation logic for physiological indicators is highly consistent between the two regions. There will not be a situation where "qualified becomes unqualified" simply by changing locations.
Comparison of Key Reproductive Centers in Hong Kong and Singapore
The following comparison is based on public information and industry exchanges. It does not constitute a recommendation and is intended only as a reference framework:
| Dimension | Representative Centers in Hong Kong (HKSH, Union, Mary) | Representative Centers in Singapore (KKH, NUH, Thomson) | |
|---|---|---|---|
| Lab Standards | Commonly use time-lapse incubators, high-resolution microscopes; some centers have AI-assisted embryo scoring systems. | Also equipped with top-tier culture devices, with long-term data accumulation in blastocyst culture continuity and cryopreservation techniques. | |
| Doctor Teams | Doctors are often trained in reproductive centers in Europe/America/Australia. Languages: Cantonese + English; Mandarin services are well covered. | Doctors are highly international; English is the main working language. Some centers have full-time Chinese coordinators. | |
| Patient Communication Model | Tends to be "doctor-led," with decision-making power resting with the doctor, requiring higher patient compliance. | Tends to be "shared decision-making," where the doctor provides options and explains pros and cons, with higher patient involvement. | |
| Estimated Cost (One Complete Cycle) | Approximately HKD 120,000–180,000 (excluding PGT) | Approximately SGD 15,000–25,000 (excluding PGT) | Costs vary significantly by location and protocol; these are approximate ranges. |
Costs are for reference only. Actual expenses will vary depending on medication choices, stimulation protocols, and the need for genetic testing.
Summary of Frequently Asked Questions
Q1: Is Hong Kong or Singapore more suitable for older patients (over 40)?
It depends on ovarian reserve, past treatment history, and the need for genetic testing. If AMH is acceptable (≥1.0) and there is no genetic risk, there is little difference between top centers in both regions. If AMH is low (<0.8) or there is repeated implantation failure, some centers in Singapore may offer more flexibility in PGT-A and embryo culture strategies. Ultimately, it comes down to the specific doctor's plan and lab data.
Q2: What is the approximate cumulative live birth rate for IVF in both regions?
According to industry data, the cumulative live birth rate (fresh + frozen) per egg retrieval cycle for people under 35 is about 50%–60% in Hong Kong and about 45%–55% in Singapore. For ages 35–38, it is about 35%–45%; for ages 38–40, about 20%–30%. For those over 40, individual variation is extremely large, and it is not recommended to rely on averages.
Q3: How far in advance do I need to prepare?
Both regions require 1–3 months in advance to complete basic tests (AMH, FSH, semen analysis, infectious disease screening, chromosome karyotyping, etc.) and submit past medical records. Some centers in Hong Kong require both partners to be present in person for registration. Singapore allows remote pre-review of some materials. Passports must be valid for more than 6 months.
Q4: If my AMH is very low, is it still worth going abroad for treatment?
A low AMH does not mean there is no chance, but expectations need to be lowered. Doctors in both regions will create a mild stimulation or natural cycle protocol based on AMH and AFC. If AMH is <0.4, it is recommended to first evaluate whether to consider an egg donation plan rather than fixating on the "success rate."
Practitioner's observation: Over the past ten years, I have seen too many patients frequently change locations because of "success rate numbers," only to waste time and money. The success rate is just one reference point. The three more important questions are: ① Which ovulation induction protocol does my ovary respond to best? ② Is the embryo lab data of this center publicly transparent? ③ If the first attempt fails, what is the potential for subsequent frozen embryo transfers or protocol adjustments?
Doctor's Advice: How to Rationally View Success Rates and Make a Choice
First, do not directly compare the "average success rates" of the two regions. Ask for stratified data matching your age and AMH.
Second, clarify the statistical method: Is it "live birth rate per transfer cycle" or "cumulative live birth rate per initiated cycle"? The latter is more valuable for reference.
Third, evaluate your core needs: Do you value the flexibility of genetic testing more (Singapore), or do you trust Hong Kong's regulatory rigor and single embryo transfer safety strategy more?
Fourth, if possible, have an online remote consultation first (some centers offer paid video consultations). Communicate directly with the doctor about the plan to judge if the communication is smooth and the plan is individualized.
Fifth, prepare a contingency plan for "if the first attempt is unsuccessful": the number of frozen embryos, the cost of another transfer, and whether a new stimulation cycle is needed—all these affect the overall success rate and cost.
#AssistedReproduction #HongKongIVF #SingaporeIVF #SuccessRateComparison #AMH #AdvancedMaternalAgeIVF #PGT #EmbryoCulture
This content is compiled based on general knowledge and clinical experience in the assisted reproduction industry and does not constitute medical advice. Please refer to the evaluation of the reproductive center doctor for specific treatment plans. Data reference time: 2024.
0 comments